GlassScriptPhysician profile
David Fridman
NPI 1538155064
$5,166.92
in general payments reported to CMS, 2019-2025
15 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $770 · 2021: $924 · 2022: $594 · 2023: $720 · 2024: $360 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,527.87 | 2019-2023 | Xarelto |
| Pfizer INC. | $589.40 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $537.14 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Allergan, INC. | $456.57 | 2019-2020 | |
| Csl Behring | $450.33 | 2022-2025 | Kcentra, Haegarda |
| E.R. Squibb & Sons, L.L.C. | $407.14 | 2020-2023 | Camzyos, Eliquis |
| Melinta Therapeutics, LLC | $392.24 | 2019-2020 | |
| Med-El Corporation | $239.40 | 2019 | |
| Mallinckrodt Hospital Products INC. | $162.67 | 2023 | Terlivaz |
| Chiesi USA, INC. | $144.62 | 2019 | |
| Alexion Pharmaceuticals, INC. | $94.25 | 2020-2022 | |
| Boston Scientific Corporation | $86.40 | 2019 | |
| Gilead Sciences, INC. | $43.50 | 2020-2021 | |
| Nabriva Therapeutics, Plc | $18.64 | 2020 | |
| Glaxosmithkline, LLC. | $16.75 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fridman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.